NCT03464084View on ClinicalTrials.gov

Interaction of Melatonin With MTNR1B Genotype on Glucose Control - Study 2

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 17, 2018

Primary Completion Date

July 19, 2022

Study Completion Date

July 19, 2022

Conditions
GlucoseCircadian RhythmMelatoninGenesLight
Interventions
DRUG

placebo

Capsules containing microcrystalline cellulose

DIETARY_SUPPLEMENT

melatonin

5 mg of melatonin per os.

OTHER

bright light

room light will be bright

OTHER

dim light

room light will be dim

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Brigham and Women's Hospital

OTHER

NCT03464084 - Interaction of Melatonin With MTNR1B Genotype on Glucose Control - Study 2 | Biotech Hunter | Biotech Hunter